Yale University-Mayo Clinic CERSI
The Yale-Mayo CERSI builds upon the numerous ongoing regulatory science-related programs across both campuses, including:
Collaboration for Research Integrity and Transparency (CRIT) at Yale
The Collaboration for Research Integrity and Transparency (CRIT) is an inter-disciplinary initiative aiming to enhance the quality and transparency of the research base for medical products. Through research, advocacy, and litigation, CRIT is focused on ensuring that the clinical evidence that supports and informs our understanding of the safety and effectiveness of pharmaceuticals, medical devices, and other medical products is accurate, comprehensive, accessible, and reliable.
Institution for Social and Policy Studies (ISPS) - Health at Yale
ISPS Health at Yale brings together scholars from across the university who are focused on developing policy-relevant research that can strengthen health care systems, help people live healthier lives and enhance the way health care is delivered.
Solomon Center for Health Law and Policy at Yale Law School
The Solomon Center for Health Law and Policy at Yale Law School is the first of its kind to focus on intersection of law and the governance, practice, and business of health care. The Center brings together leading experts and practitioners from the public and private sectors to address cutting-edge questions of health law and policy, and to train the next generation of top health lawyers, industry leaders, policymakers, and academics.
Yale Interdisciplinary Center for Bioethics
The Yale Interdisciplinary Center for Bioethics exists to encourage informed discussion of the issues raised by our increasing powers over life. The research program includes not only biomedical ethics but also environmental ethics, animal ethics, the ethics of scientific research, business and professional ethics, and ethics issues relating to new technologies.
Yale School of Public Health Regulatory Affairs Track
The Regulatory Affairs Track prepares MPH students for roles in the areas of quality control and regulatory affairs. The approach of the track is multidisciplinary to reflect the full array of issues addressed in regulatory affairs: legal requirements, ethics, clinical trials, epidemiology, risk analysis, and leadership and change management.
Yale Tobacco Center of Regulatory Science (TCORS)
With the overarching goal of reducing addiction to tobacco products, the Yale Tobacco Center of Regulatory Science (TCORS) conducts programmatic research to examine the influence of flavors, and related factors, on preference for and addiction to tobacco products.
Yale University Center for Biomedical Innovation and Technology (CBIT)
The Yale University Center for Biomedical Innovation and Technology (CBIT) is an interdisciplinary initiative to foster greater innovation in medical technology. It is a consortium of engineers, clinicians, scientists, innovators and entrepreneurs to help incubate, support, implement, and potentially bring to market novel technical approaches to address under-met clinical needs.
The Mayo Clinic Kern Center for the Science of Health Care Delivery applies innovative science and data to evaluate the quality, safety and value of health care globally and improve real-world experiences for patients.
Mayo Clinic Center for Individualized Medicine (CIM)
The Center for Individualized Medicine aims to solve the clinical challenges of today and tomorrow by bringing the latest discoveries from the research laboratory to your doctor's fingertips in the form of new genomics-based tests and treatments.
Mayo Clinic Center for Regenerative Medicine
The Center for Regenerative Medicine was established in 2011 to develop new clinical applications that address the unmet needs of patients suffering from chronic diseases or injuries. In addition to developing regenerative medicine therapies for patients, the center is also committed to training the next generation of clinicians and scientists in the latest regenerative medicine applications, offering continuing education opportunities about regenerative medicine to Mayo Clinic faculty and staff, and educating patients and the public about the promise of and latest advances in regenerative medicine.